CLINICAL TRIALS BY STATE

Clinical Trials in Tennessee

12+ recruiting studies in Tennessee, updated in real time and displayed in plain English.

BROWSE BY CONDITION IN TENNESSEE

Bladder CancerBrain Tumor / GliomaBreast CancerCervical CancerColorectal CancerEndometrial / Uterine CancerHead & Neck CancerKidney / Renal Cell CarcinomaLeukemia (AML)Leukemia (CLL)Liver / Hepatocellular CarcinomaLung Cancer (NSCLC)Lung Cancer (SCLC)Lymphoma (Non-Hodgkin)MelanomaMultiple MyelomaOvarian CancerPancreatic Cancer

RECRUITING TRIALS IN TENNESSEE

RECRUITINGPhase 3

Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute UVA Exposure vs. a 24-Minute UVA Exposure on Eyes With Ectatic Corneal Diseases

NCT07124910 · Atlanta, Woolfson Eye Institute
RECRUITINGPhase 3

Vitamin D for Prostate Endocrine Therapy

NCT05838716 · Newark, Helen F Graham Cancer Center
RECRUITINGPhase 3

Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

NCT07325292 · Cullman, North Central Neurology Associates- Site Number : 8401100
RECRUITINGPhase 1

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

NCT06034002 · Duarte, City of Hope Medical Center
RECRUITINGPhase 3

Fontan Udenafil Exercise Longitudinal Assessment Trial - 2

NCT05918211 · Phoenix, Phoenix Children's Hospital
RECRUITINGPhase 1

Study of ART6043 in Advanced/Metastatic Solid Tumors Patients (POLKA)

NCT05898399 · Grand Rapids, South Texas Accelerated Research Therapeutics (START) - Midwest
RECRUITINGPhase 3

Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation

NCT06830798 · Phoenix, Research Site
RECRUITINGPhase 1

A Study of PHN-012 in Patients With Advanced Solid Tumors

NCT07127874 · Los Angeles, PHN-012-001 Site
RECRUITINGPhase 1

A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors

NCT06792552 · Orlando, Sarah Cannon Research Institute (SCRI) - Lake Nona
RECRUITINGPhase 3

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

NCT06617325 · Avondale, Sl0044 50058
RECRUITINGPhase 3

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

NCT07037433 · Daphne, Alliance For Multispecialty Research - Daphne
RECRUITINGPhase 3

A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

NCT06609226 · Birmingham, Univ of Alabama Birmingham

COMMON QUESTIONS

How many clinical trials are available in Tennessee?

There are currently 12+ recruiting clinical trials in Tennessee listed on ClinicalTrials.gov. Clinicals AI makes these easier to browse with plain-language summaries and condition filters.

How do I join a clinical trial in Tennessee?

Browse the listings above, review eligibility criteria, and submit a contact request. A study coordinator will follow up to discuss your eligibility and next steps.

Are clinical trials in Tennessee free?

Most trials cover the investigational treatment and study-related visits at no cost. Some also offer compensation for time and travel. Confirm cost details with each trial coordinator.

What conditions have trials in Tennessee?

Tennessee hosts trials across cancer, cardiovascular disease, diabetes, neurological conditions, mental health, autoimmune disease, and rare conditions. Browse by condition using the links above.

OTHER STATES

CaliforniaNew YorkTexasFloridaPennsylvaniaOhioIllinoisMassachusettsMichiganWashington